Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.

S.A.B.E. van Acker; E. Boven; K. Kuiper; D.J. van den Berg; J.A. Grimbergen; K. Kramer; A. Bast; W.J.F. van der Vijgh

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.

S.A.B.E. van Acker, E. Boven, K. Kuiper, D.J. van den Berg, J.A. Grimbergen, K. Kramer, A. Bast, W.J.F. van der Vijgh

Medicinal chemistry

Research output: Contribution to Journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1747-1754
Journal	Clinical Cancer Research
Volume	3
Publication status	Published - 1997

Handle.net

Persistent link

Cite this

@article{690f2b318e114d5c994404fcff526002,

title = "Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.",

author = "{van Acker}, S.A.B.E. and E. Boven and K. Kuiper and {van den Berg}, D.J. and J.A. Grimbergen and K. Kramer and A. Bast and {van der Vijgh}, W.J.F.",

year = "1997",

language = "English",

volume = "3",

pages = "1747--1754",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.

AU - van Acker, S.A.B.E.

AU - Boven, E.

AU - Kuiper, K.

AU - van den Berg, D.J.

AU - Grimbergen, J.A.

AU - Kramer, K.

AU - Bast, A.

AU - van der Vijgh, W.J.F.

PY - 1997

Y1 - 1997

M3 - Article

VL - 3

SP - 1747

EP - 1754

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -